Cargando…
Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
SIMPLE SUMMARY: The high recurrence risk and poor prognosis of metastatic endometrial cancer are the main focus of interventional therapy. In view of this, we established in vitro and in vivo metastasis models and explored the underlying mechanisms of the epithelial-mesenchymal transition (EMT) proc...
Autores principales: | Chen, Hsin-Yuan, Chiang, Yi-Fen, Huang, Jia-Syuan, Huang, Tsui-Chin, Shih, Yin-Hwa, Wang, Kai-Lee, Ali, Mohamed, Hong, Yong-Han, Shieh, Tzong-Ming, Hsia, Shih-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001359/ https://www.ncbi.nlm.nih.gov/pubmed/33799801 http://dx.doi.org/10.3390/cancers13061236 |
Ejemplares similares
-
Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice
por: Wu, Chi-Hao, et al.
Publicado: (2016) -
Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
por: Chen, Hsin-Yuan, et al.
Publicado: (2017) -
Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
por: Lin, Po-Han, et al.
Publicado: (2020) -
Perspectives on the Role of Isoliquiritigenin in Cancer
por: Wang, Kai-Lee, et al.
Publicado: (2021) -
Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)